From: kens5.com
Over-the-counter pain relievers like aspirin might reduce the recurrence of breast cancer. A critical study is just being launched in San Antonio at the UT Health Science Center to find out more.
Right now, the UT Health Science Center is looking for about 80 women. The on-going study will be based on findings published by the Cancer Research Journal.
“I just wanted to help out,” said Debbie Mason, who just completed the study.
Mason is part of a small group that could prove an anti-inflammatory pill, like an aspirin or fish oil, may help postmenopausal, overweight breast cancer survivors in the long run.
“They could potentially take aspirin in addition to their pill hormonal therapies and cut their rate further down in terms of recurring cancer and maybe improve their survival,” said Dr. Andrew Brenner.
New research shows obese women may cut their chances of recurrences in half by taking aspirin and other non-steroidal anti-inflammatory drugs.
However, since it’s only a preliminary findings Dr. Andrew Brenner is conducting the study to find out if in fact that’s the case. It’s happening at The Cancer Therapy & Research Center for the U-T Health Science Center.
Dr. Brenner said this study is critical since overweight women who survive breast cancer do not do as well as other survivors.
“The bottom line is it looks like inflammation that’s happening in our overweight and obese patients is driving the production of estrogen in breast tissue,” said Dr. Brenner.
The study is 28 days long. During that time, the administrators will study patients who take an aspirin or fish oil, or both, for the, draw and analyze their blood.
Dr. Brenner will launch a second study next year, which will compare findings with newly diagnosed cancer patients.
Women interested in participating should call 210-450-7549. Participants will be compensated $150.
Barbara Jacoby is an award winning blogger that has contributed her writings to multiple online publications that have touched readers worldwide.